To determine whether DAC-induced upregulation of CD80 is a general phenomenon, 6 human leukemia cell lines and 2 human lymphoma cell lines were treated with DAC (1 μM for 72 hours) followed by RT-PCR analysis. This evidence concerns the gene CD80 and leukemia.